Company Name: Vericel Corporation
Vericel Corporation is engaged in the development of patient specific expanded cellular therapies. The company’s autologous cell therapy products include:
- Carticel®: Autologous chondrocyte implant designed to treat cartilage defects in the knee
- Epicel®: Permanent skin replacement designed to treat deep dermal or full thickness burns that make up thirty percent or more of total body surface area
Ticker Symbol: VCEL (NASDAQ)
Company Website: http://vcel.com
Social Media:
Headquarters: Cambridge, MA
